位置:首页 > 蛋白库 > GGR_SULAC
GGR_SULAC
ID   GGR_SULAC               Reviewed;         452 AA.
AC   Q4JA33;
DT   07-OCT-2020, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   03-AUG-2022, entry version 101.
DE   RecName: Full=Digeranylgeranylglycerophospholipid reductase;
DE            Short=DGGGPL reductase;
DE            EC=1.3.-.- {ECO:0000269|PubMed:18375567, ECO:0000269|PubMed:24954619};
DE   AltName: Full=2,3-bis-O-geranylgeranylglyceryl phosphate reductase;
DE   AltName: Full=Geranylgeranyl diphosphate reductase;
DE            Short=GGPP reductase;
DE   AltName: Full=Geranylgeranyl reductase {ECO:0000303|PubMed:18375567};
DE            Short=GGR {ECO:0000303|PubMed:18375567};
GN   OrderedLocusNames=Saci_0986 {ECO:0000312|EMBL:AAY80347.1};
OS   Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC
OS   15157 / NCIMB 11770).
OC   Archaea; Crenarchaeota; Thermoprotei; Sulfolobales; Sulfolobaceae;
OC   Sulfolobus.
OX   NCBI_TaxID=330779;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770;
RX   PubMed=15995215; DOI=10.1128/jb.187.14.4992-4999.2005;
RA   Chen L., Bruegger K., Skovgaard M., Redder P., She Q., Torarinsson E.,
RA   Greve B., Awayez M., Zibat A., Klenk H.-P., Garrett R.A.;
RT   "The genome of Sulfolobus acidocaldarius, a model organism of the
RT   Crenarchaeota.";
RL   J. Bacteriol. 187:4992-4999(2005).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, FLAVIN-BINDING, COFACTOR, AND PATHWAY.
RX   PubMed=18375567; DOI=10.1128/jb.00082-08;
RA   Sato S., Murakami M., Yoshimura T., Hemmi H.;
RT   "Specific partial reduction of geranylgeranyl diphosphate by an enzyme from
RT   the thermoacidophilic archaeon Sulfolobus acidocaldarius yields a reactive
RT   prenyl donor, not a dead-end product.";
RL   J. Bacteriol. 190:3923-3929(2008).
RN   [3] {ECO:0007744|PDB:3ATQ, ECO:0007744|PDB:3ATR}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH FADH2, FUNCTION,
RP   COFACTOR, DISULFIDE BOND, SUBUNIT, AND MUTAGENESIS OF CYS-47; TYR-215;
RP   TRP-217 AND PHE-219.
RX   PubMed=21515284; DOI=10.1016/j.jmb.2011.04.002;
RA   Sasaki D., Fujihashi M., Iwata Y., Murakami M., Yoshimura T., Hemmi H.,
RA   Miki K.;
RT   "Structure and mutation analysis of archaeal geranylgeranyl reductase.";
RL   J. Mol. Biol. 409:543-557(2011).
RN   [4] {ECO:0007744|PDB:4OPC, ECO:0007744|PDB:4OPD, ECO:0007744|PDB:4OPG, ECO:0007744|PDB:4OPI, ECO:0007744|PDB:4OPL, ECO:0007744|PDB:4OPT, ECO:0007744|PDB:4OPU}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF WILD-TYPE AND MUTANTS HIS-91;
RP   PHE-206; LEU-219; HIS-377 AND PHE-206/HIS-377 IN COMPLEXES WITH FAD;
RP   GERANYLGERANYL PYROPHOSPHATE AND PHOSPHATIDYLGLYCEROL, FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, DISULFIDE BOND,
RP   MUTAGENESIS OF GLY-91; ILE-206; PHE-219 AND LEU-377, AND REACTION
RP   MECHANISM.
RX   PubMed=24954619; DOI=10.1016/j.str.2014.05.007;
RA   Kung Y., McAndrew R.P., Xie X., Liu C.C., Pereira J.H., Adams P.D.,
RA   Keasling J.D.;
RT   "Constructing tailored isoprenoid products by structure-guided modification
RT   of geranylgeranyl reductase.";
RL   Structure 22:1028-1036(2014).
CC   -!- FUNCTION: Is involved in the reduction of 2,3-
CC       digeranylgeranylglycerophospholipids (unsaturated archaeols) into 2,3-
CC       diphytanylglycerophospholipids (saturated archaeols) in the
CC       biosynthesis of archaeal membrane lipids. Catalyzes the formation of
CC       archaetidic acid (2,3-di-O-phytanyl-sn-glyceryl phosphate) from 2,3-di-
CC       O-geranylgeranylglyceryl phosphate (DGGGP) via the hydrogenation of
CC       each double bond of the isoprenoid chains. Is not active with NADPH or
CC       NADH as an electron donor; the physiological reducing agent is unknown.
CC       Is also active on the more upstream precursors of membrane lipid
CC       biosynthesis, catalyzing the complete reduction of 3-O-
CC       geranylgeranylglyceryl phosphate (GGGP) to 3-O-phytanylglyceryl
CC       phosphate, and the partial reduction of geranylgeranyl diphosphate
CC       (GGPP) to phytyl diphosphate, thus reducing three of four GGPP double
CC       bonds and preserving the allylic double bond (at position 2). This
CC       reaction product is a reactive prenyl donor, which can be used as a
CC       substrate by archaeal prenyltransferases such as GGGP synthases.
CC       {ECO:0000269|PubMed:18375567, ECO:0000269|PubMed:21515284,
CC       ECO:0000269|PubMed:24954619}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=8 A + a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid = a 2,3-
CC         bis-O-(geranylgeranyl)-sn-glycerol 1-phospholipid + 8 AH2;
CC         Xref=Rhea:RHEA:64376, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:138139, ChEBI:CHEBI:138140;
CC         Evidence={ECO:0000305|PubMed:18375567, ECO:0000305|PubMed:24954619};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64378;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2,3-bis-O-(phytanyl)-sn-glycerol 1-phosphate + 8 A = 2,3-bis-
CC         O-(geranylgeranyl)-sn-glycerol 1-phosphate + 8 AH2;
CC         Xref=Rhea:RHEA:64368, ChEBI:CHEBI:13193, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:58837, ChEBI:CHEBI:73125;
CC         Evidence={ECO:0000269|PubMed:18375567};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64370;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4 A + sn-3-O-phytanylglycerol 1-phosphate = 4 AH2 + sn-3-O-
CC         (geranylgeranyl)glycerol 1-phosphate; Xref=Rhea:RHEA:64388,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:17499, ChEBI:CHEBI:57677,
CC         ChEBI:CHEBI:152569; Evidence={ECO:0000269|PubMed:18375567};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64390;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 A + phytyl diphosphate = (2E,6E,10E)-geranylgeranyl
CC         diphosphate + 3 AH2; Xref=Rhea:RHEA:64380, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:58756, ChEBI:CHEBI:75434;
CC         Evidence={ECO:0000269|PubMed:18375567, ECO:0000269|PubMed:24954619};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:64382;
CC         Evidence={ECO:0000305|PubMed:18375567};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:21515284, ECO:0000269|PubMed:24954619,
CC         ECO:0000305|PubMed:18375567};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:21515284,
CC       ECO:0000269|PubMed:24954619};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=kcat is 0.40 min(-1) for the reduction of GGPP to the hexahydro-
CC         product H(6)GGPP. {ECO:0000269|PubMed:24954619};
CC       pH dependence:
CC         Optimum pH is 5.5 for the reduction of GGPP to the hexahydro-product
CC         H(6)GGPP. {ECO:0000269|PubMed:24954619};
CC       Temperature dependence:
CC         Optimum temperature is 55 degrees Celsius for the reduction of GGPP
CC         to the hexahydro-product H(6)GGPP. {ECO:0000269|PubMed:24954619};
CC   -!- PATHWAY: Membrane lipid metabolism; glycerophospholipid metabolism.
CC       {ECO:0000305|PubMed:18375567}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:21515284}.
CC   -!- SIMILARITY: Belongs to the geranylgeranyl reductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000077; AAY80347.1; -; Genomic_DNA.
DR   RefSeq; WP_011277849.1; NC_007181.1.
DR   PDB; 3ATQ; X-ray; 1.85 A; A=1-452.
DR   PDB; 3ATR; X-ray; 1.80 A; A=1-452.
DR   PDB; 4OPC; X-ray; 1.40 A; A=1-452.
DR   PDB; 4OPD; X-ray; 1.81 A; A/B=1-452.
DR   PDB; 4OPG; X-ray; 2.07 A; A=1-452.
DR   PDB; 4OPI; X-ray; 2.24 A; A=1-452.
DR   PDB; 4OPL; X-ray; 2.51 A; A=1-452.
DR   PDB; 4OPT; X-ray; 2.60 A; A=1-452.
DR   PDB; 4OPU; X-ray; 2.70 A; A=1-452.
DR   PDBsum; 3ATQ; -.
DR   PDBsum; 3ATR; -.
DR   PDBsum; 4OPC; -.
DR   PDBsum; 4OPD; -.
DR   PDBsum; 4OPG; -.
DR   PDBsum; 4OPI; -.
DR   PDBsum; 4OPL; -.
DR   PDBsum; 4OPT; -.
DR   PDBsum; 4OPU; -.
DR   AlphaFoldDB; Q4JA33; -.
DR   SMR; Q4JA33; -.
DR   STRING; 330779.Saci_0986; -.
DR   EnsemblBacteria; AAY80347; AAY80347; Saci_0986.
DR   GeneID; 3473654; -.
DR   KEGG; sai:Saci_0986; -.
DR   PATRIC; fig|330779.12.peg.946; -.
DR   eggNOG; arCOG00570; Archaea.
DR   HOGENOM; CLU_024648_0_0_2; -.
DR   OMA; WYFPRTE; -.
DR   BRENDA; 1.3.7.11; 6160.
DR   UniPathway; UPA00940; -.
DR   EvolutionaryTrace; Q4JA33; -.
DR   Proteomes; UP000001018; Chromosome.
DR   GO; GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   GO; GO:0006650; P:glycerophospholipid metabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR011777; Geranylgeranyl_Rdtase_fam.
DR   Pfam; PF01266; DAO; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   TIGRFAMs; TIGR02032; GG-red-SF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; FAD; Flavoprotein; Lipid biosynthesis;
KW   Lipid metabolism; Oxidoreductase; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome.
FT   CHAIN           1..452
FT                   /note="Digeranylgeranylglycerophospholipid reductase"
FT                   /id="PRO_0000450802"
FT   BINDING         15..16
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         35..36
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         45..50
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         55
FT                   /ligand="a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid"
FT                   /ligand_id="ChEBI:CHEBI:138139"
FT                   /evidence="ECO:0000305|PubMed:24954619,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         122
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         288
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         297
FT                   /ligand="a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid"
FT                   /ligand_id="ChEBI:CHEBI:138139"
FT                   /evidence="ECO:0000305|PubMed:24954619,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         300..301
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:4OPC"
FT   BINDING         340
FT                   /ligand="a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid"
FT                   /ligand_id="ChEBI:CHEBI:138139"
FT                   /evidence="ECO:0000305|PubMed:24954619,
FT                   ECO:0007744|PDB:4OPC"
FT   DISULFID        310..335
FT                   /evidence="ECO:0000269|PubMed:21515284,
FT                   ECO:0000269|PubMed:24954619, ECO:0007744|PDB:3ATQ,
FT                   ECO:0007744|PDB:3ATR, ECO:0007744|PDB:4OPC"
FT   MUTAGEN         47
FT                   /note="C->A,M: Almost loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         47
FT                   /note="C->S: Seems to be able to reduce only one double
FT                   bond of GGGP."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         91
FT                   /note="G->H: Halts the reduction of GGPP at H(2)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   MUTAGEN         206
FT                   /note="I->F: Increases reduction rate of GGPP to H(6)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   MUTAGEN         215
FT                   /note="Y->F,L: Moderate decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         217
FT                   /note="W->L: Large decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         219
FT                   /note="F->L: Halts the reduction of GGPP at H(4)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   MUTAGEN         219
FT                   /note="F->L: Slight decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:21515284"
FT   MUTAGEN         377
FT                   /note="L->H: Increases reduction rate of GGPP to H(6)GGPP."
FT                   /evidence="ECO:0000269|PubMed:24954619"
FT   STRAND          2..5
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           15..24
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:3ATR"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           39..41
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           53..59
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           66..68
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          69..79
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          86..96
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           98..111
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          115..128
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          131..139
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            140..143
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          144..149
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          151..155
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           158..160
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          182..194
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            197..200
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          201..205
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          214..236
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           241..252
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          256..270
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   STRAND          283..285
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           287..290
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           301..321
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           326..329
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           331..339
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           341..356
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           359..367
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           373..382
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           387..396
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   TURN            397..399
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           405..408
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           409..424
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           430..432
FT                   /evidence="ECO:0007829|PDB:4OPC"
FT   HELIX           433..451
FT                   /evidence="ECO:0007829|PDB:4OPC"
SQ   SEQUENCE   452 AA;  50623 MW;  1C94FC2B23BA3CDF CRC64;
     MKELKYDVLI IGGGFAGSSA AYQLSRRGLK ILLVDSKPWN RIGDKPCGDA VSKAHFDKLG
     MPYPKGEELE NKINGIKLYS PDMQTVWTVN GEGFELNAPL YNQRVLKEAQ DRGVEIWDLT
     TAMKPIFEDG YVKGAVLFNR RTNEELTVYS KVVVEATGYS RSFRSKLPPE LPITEDLDDK
     DADVAYREVL LTKEDIEDHD YLRIFIDQET SPGGYWWYFP KGKNKVNVGL GIQGGMGYPS
     IHEYYKKYLD KYAPDVDKSK LLVKGGALVP TRRPLYTMAW NGIIVIGDSG FTVNPVHGGG
     KGSAMISGYC AAKAILSAFE TGDFSASGLW DMNICYVNEY GAKQASLDIF RRFLQKLSND
     DINYGMKKKI IKEEDLLEAS EKGDLHLSVA DKAMRVISGL GRPSLLFKLK AVAESMKKIK
     ELYLNYPRSP SSLGSWRREV DNVLTEFNKS LS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025